TrialHeadache2018

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.

David W Dodick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.